Thomas Loustau

488 total citations
16 papers, 245 citations indexed

About

Thomas Loustau is a scholar working on Immunology and Allergy, Immunology and Oncology. According to data from OpenAlex, Thomas Loustau has authored 16 papers receiving a total of 245 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology and Allergy, 8 papers in Immunology and 5 papers in Oncology. Recurrent topics in Thomas Loustau's work include Cell Adhesion Molecules Research (9 papers), Immunotherapy and Immune Responses (5 papers) and Immune cells in cancer (4 papers). Thomas Loustau is often cited by papers focused on Cell Adhesion Molecules Research (9 papers), Immunotherapy and Immune Responses (5 papers) and Immune cells in cancer (4 papers). Thomas Loustau collaborates with scholars based in France, Germany and United Kingdom. Thomas Loustau's co-authors include Gertraud Orend, Raphaël Carapito, Devadarssen Murdamoothoo, Alev Yılmaz, Zhen Sun, Nicodème Paul, Kim S. Midwood, Claire Deligne, Nathalie Salomé and Chérine Abou Fayçal and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Cell Science and International Journal of Molecular Sciences.

In The Last Decade

Thomas Loustau

15 papers receiving 245 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Loustau France 9 104 92 85 79 40 16 245
Beatriz Cardeñes Spain 7 39 0.4× 79 0.9× 94 1.1× 190 2.4× 19 0.5× 9 307
Karolin Nowak United Kingdom 7 55 0.5× 34 0.4× 158 1.9× 141 1.8× 42 1.1× 7 324
Katharina Mattenheimer Germany 8 90 0.9× 22 0.2× 140 1.6× 74 0.9× 12 0.3× 10 271
Matteo Ponzo France 4 136 1.3× 36 0.4× 93 1.1× 66 0.8× 66 1.6× 6 253
Rochna Chand Australia 5 24 0.2× 42 0.5× 101 1.2× 36 0.5× 10 0.3× 8 212
Zachary Morrow United States 6 93 0.9× 13 0.1× 65 0.8× 119 1.5× 29 0.7× 12 240
Matthew P. Williams United Kingdom 9 26 0.3× 228 2.5× 42 0.5× 138 1.7× 112 2.8× 9 369
Alexander C. Lewis Australia 8 91 0.9× 25 0.3× 130 1.5× 204 2.6× 61 1.5× 11 371
Anaïs Jiménez-Reinoso Spain 9 96 0.9× 11 0.1× 88 1.0× 97 1.2× 22 0.6× 15 243
Abhijit G. Banerjee United States 9 53 0.5× 25 0.3× 29 0.3× 163 2.1× 52 1.3× 15 317

Countries citing papers authored by Thomas Loustau

Since Specialization
Citations

This map shows the geographic impact of Thomas Loustau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Loustau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Loustau more than expected).

Fields of papers citing papers by Thomas Loustau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Loustau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Loustau. The network helps show where Thomas Loustau may publish in the future.

Co-authorship network of co-authors of Thomas Loustau

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Loustau. A scholar is included among the top collaborators of Thomas Loustau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Loustau. Thomas Loustau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Kaur, Amanpreet, Caroline Spenlé, Emmanuel Donnadieu, et al.. (2024). Targeting the MAtrix REgulating MOtif abolishes several hallmarks of cancer, triggering antitumor immunity. Proceedings of the National Academy of Sciences. 121(42). e2404485121–e2404485121. 5 indexed citations
2.
Rovere, Marco De, Amina Aït-Ammar, Muhammad Kashif, et al.. (2024). BCL11b interacts with RNA and proteins involved in RNA processing and developmental diseases. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1867(4). 195065–195065.
3.
Wallet, Clémentine, et al.. (2023). Targeting and eradicating latent CNS reservoirs of HIV-1: Original strategies and new models. Biochemical Pharmacology. 214. 115679–115679. 2 indexed citations
4.
Gschwandtner, Martha, Claire Deligne, Thomas Loustau, et al.. (2023). Investigating Chemokine-Matrix Networks in Breast Cancer: Tenascin-C Sets the Tone for CCL2. International Journal of Molecular Sciences. 24(9). 8365–8365. 3 indexed citations
5.
Loustau, Thomas, Suchithra Poilil Surendran, Uwe Hansen, et al.. (2023). Infiltrating CD8+ T cells and M2 macrophages are retained in tumor matrix tracks enriched in low tension fibronectin fibers. Matrix Biology. 116. 1–27. 18 indexed citations
6.
Fayçal, Chérine Abou, André Oszwald, Miguel Cosenza‐Contreras, et al.. (2022). An adapted passive model of anti-MPO dependent crescentic glomerulonephritis reveals matrix dysregulation and is amenable to modulation by CXCR4 inhibition. Matrix Biology. 106. 12–33. 6 indexed citations
7.
Loustau, Thomas, Chérine Abou Fayçal, Pia Abel zur Wiesch, et al.. (2022). Modulating tenascin-C functions by targeting the MAtrix REgulating MOtif, “MAREMO”. Matrix Biology. 108. 20–38. 11 indexed citations
8.
Loustau, Thomas, Angélique Pichot, Anne Molitor, et al.. (2022). Dicer1 deficient mice exhibit premature aging and metabolic perturbations in adipocytes. iScience. 25(10). 105149–105149. 4 indexed citations
9.
Richert, Ludovic, Thomas Loustau, Michael C. Hodder, et al.. (2022). Wnt signaling is boosted during intestinal regeneration by a CD44-positive feedback loop. Cell Death and Disease. 13(2). 168–168. 18 indexed citations
10.
Yılmaz, Alev, Thomas Loustau, Nathalie Salomé, et al.. (2022). Advances on the roles of tenascin-C in cancer. Journal of Cell Science. 135(18). 38 indexed citations
11.
Murdamoothoo, Devadarssen, Zhen Sun, Alev Yılmaz, et al.. (2021). Tenascin‐C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression. EMBO Molecular Medicine. 13(6). e13270–e13270. 44 indexed citations
12.
Assche, Jeanne Van, et al.. (2021). Suicide gene therapy in cancer and HIV-1 infection: An alternative to conventional treatments. Biochemical Pharmacology. 197. 114893–114893. 13 indexed citations
13.
Spenlé, Caroline, Thomas Loustau, Hélène Burckel, et al.. (2021). Impact of Tenascin-C on Radiotherapy in a Novel Syngeneic Oral Squamous Cell Carcinoma Model With Spontaneous Dissemination to the Lymph Nodes. Frontiers in Immunology. 12. 636108–636108. 8 indexed citations
14.
Loustau, Thomas, Chérine Abou Fayçal, Devadarssen Murdamoothoo, et al.. (2021). Novel Human Tenascin-C Function-Blocking Camel Single Domain Nanobodies. Frontiers in Immunology. 12. 635166–635166. 17 indexed citations
15.
Deligne, Claire, Devadarssen Murdamoothoo, Martha Gschwandtner, et al.. (2020). Matrix-Targeting Immunotherapy Controls Tumor Growth and Spread by Switching Macrophage Phenotype. Cancer Immunology Research. 8(3). 368–382. 48 indexed citations
16.
Loustau, Thomas, et al.. (2020). Murine double minute-2 mediates exercise-induced angiogenesis in adipose tissue of diet-induced obese mice. Microvascular Research. 130. 104003–104003. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026